Unfavourable effects of long-term adjuvant chemotherapy with Endoxan in radically operated bronchogenic carcinoma
- 31 August 1971
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer (1965)
- Vol. 7 (4), 285-294
- https://doi.org/10.1016/0014-2964(71)90071-5
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Bronchogenic carcinoma: Nitrogen mustard as a surgical adjuvant and factors influencing survival.University surgical adjuvant lung projectCancer, 1970
- COMBINED SURGERY AND CHEMOTHERAPY FOR CARCINOMA OF THE BRONCHUSThe Lancet, 1970
- COMBINED SURGERY AND CHEMOTHERAPY FOR CARCINOMA OF BRONCHUSThe Lancet, 1970
- Triple drug therapy in testicular tumorsCancer, 1969
- Cytoxan as an adjuvant to surgery for lung cancerJournal of Surgical Oncology, 1969
- VETERANS ADMINISTRATION SURGICAL ADJUVANT LUNG CANCER CHEMOTHERAPY STUDY: PRESENT STATUSThe Journal of Thoracic and Cardiovascular Surgery, 1962
- Combined surgery and chemotherapy in the treatment of malignant tumorsCancer, 1961
- CLINICAL STUDIES OF ACTINOMYCIN D WITH SPECIAL REFERENCE TO WILMS' TUMOR IN CHILDREN*Annals of the New York Academy of Sciences, 1960
- ADJUVANT USE OF CHEMOTHERAPY IN THE SURGICAL TREATMENT OF CANCERJAMA, 1958